Introduction kinase also known as protein kinase B (PKB) is a potent survival kinase that exerts its effects by acting on key Huntington's disease (HD) is a neurodegenerative disorsubstrates such as components of cell death machinery der characterized by involuntary movements, personalor transcription factors (for a review, see Brunet et al., ity changes, and dementia. The neuropathology of HD 2001). involves a selective death of medium spiny neurons of
In this report, we show that IGF-1 and Akt inhibit the striatum. The mutation that causes disease is an mutant huntingtin-induced cell death and formation of abnormal expansion of a polyglutamine (polyQ) stretch intranuclear inclusions of polyQ-huntingtin. In addition, in the N terminus of the 350 kDa protein huntingtin, and we demonstrate that huntingtin phosphorylation by Akt a strong inverse correlation exists between the age at at serine 421 regulates mutant huntingtin-induced toxiconset in patients and the number of glutamines (Gusella ity in primary cultures of striatal neurons. These findings and MacDonald, 2000).
reveal that the specific neuroprotective effect of the The mechanism by which mutant huntingtin induces IGF-1/Akt pathway in HD is mediated by direct phosselective death of striatal neurons is not well underphorylation of huntingtin. Finally, we present evidence stood. Several studies have revealed a series of events that Akt is altered in HD patients, which further supports that could ultimately lead to the death of neurons in the a role of the IGF-1/Akt pathway in the context of HD. striatum (for a review, see Humbert and Saudou, 2001 increase in the formation of intranuclear inclusions (Sauand leads to a decrease in the formation of intranuclear inclusions ( Figure 1D ). Although we could not evaluate dou et al., 1998). Here, we tested the effect of another neurotrophic factor, IGF-1, on striatal neurons expressthe effect of PI3K inhibition on mutant huntingtininduced cell death due to the high toxicity of the PI3K ing mutant huntingtin. As expected, the 480 amino acid fragment that contains a mutant stretch of 68 glutamines inhibitor LY in striatal neurons, we found an increase in the percentage of striatal neurons containing intra-(480-68) induces a statistically significant decrease in cell survival compared to the wild-type 480-17 connuclear inclusions when treated with subtoxic doses of LY (100 nM; data not shown). Taken together, these struct. Interestingly, treatment with IGF-1 completely blocks mutant huntingtin-induced death of striatal neufindings indicate that in striatal neurons, IGF-1, through the activation of the PI3K/Akt pathway, is able to block rons ( Figure 1A we generated huntingtin GST-fused proteins containing with 480-17 or 480-68 with Akt c.a. or k.n. We found that Akt c.a. induces a phosphorylation of huntingtin either an intact S421 or a serine to alanine mutation at this site. As shown in Figure 2B , GST-hu-htt is phosphorat S421 (Figure 2D ), indicating that active Akt alone is sufficient to induce the phosphorylation of huntingtin at ylated, while GST-hu-htt-S421A is no longer detectably phosphorylated by Akt. This shows that S421 is a site S421. We then generated versions of 480-17/68 constructs with an S421A mutation and expressed them in of phosphorylation by Akt in huntingtin.
To unequivocally identify S421 as an Akt site, we 293T cells with Akt c.a. (Figure 2E ). Levels of huntingtin were monitored using the 4C8 antibody, revealing no raised a polyclonal antibody that specifically recognizes huntingtin phosphorylated at S421. As shown in Figure differences in expression due to the S421A mutation. 2C, the antibody to phosphorylated huntingtin S421
The anti-P-htt-S421 recognizes 480-17/68 fragments of (anti-P-htt-S421) recognizes GST-hu-htt that was incuhuntingtin but fails to recognize the proteins with the bated with Akt c.a. but fails to recognize nonphosphory-S421A mutation. Thus, we demonstrate that Akt phoslated GST-hu-htt or GST-hu-htt-S421A. These results phorylates the 480-17/68 forms of huntingtin in 293T demonstrate that anti-P-htt-S421 specifically recogcells at S421. nizes huntingtin when phosphorylated at S421 and that To test whether endogenous huntingtin becomes Akt phosphorylates huntingtin at S421 in vitro. Similar phosphorylated in response to IGF-1, we exposed huresults were obtained with the mouse huntingtin seman neuroblastoma SH-SY5Y cells to IGF-1. This treatquences (see Supplemental Figure S3 Figure 3B ). This indicates that IGF-1, Discussion in addition to promoting survival through the phosphorylation of huntingtin at serine 421, elicits some neuroproWe show here that phosphorylation of S421 in polyQhuntingtin abrogates its proapoptotic activity. The abtection against mutant huntingtin by other mechanisms.
We next asked whether constitutive phosphorylation sence of phosphorylation at S421 or its constitutive phosphorylation do not appear to affect the level of of huntingtin at S421 is able to reduce toxicity of mutant huntingtin. To test this hypothesis, we generated a 480-expression or the subcellular localization of huntingtin. Further, phosphorylation of huntingtin at S421 does not 68 construct in which serine 421 is changed into an aspartic acid to mimic constitutive phosphorylation. modify its ability to be ubiquitinated or degraded (data not shown). In addition, we do not observe any effects With this S421D mutation, we found that polyQ-huntingtin is no longer able to induce neuronal death ( Figure 3C) of the phosphorylation at S421 on the cleavage of huntingtin by calpain or caspases -1 and -3 (data not shown). and leads to a reduction in the percentage of neurons containing intranuclear inclusions ( Figure 3D ). The effect Huntingtin interacts with several proteins (Humbert and Saudou, 2001 ). It is possible that phosphorylation alters is not due to differences in expression levels, since the the ability of huntingtin to interact with a yet to be identinine neurodegenerative disorders, including HD. Our experiments demonstrate that toxicity of mutant huntingtin fied protein.
Although we find that the complete neuroprotective can be inhibited by direct phosphorylation and raise the possibility that phosphorylation by Akt could also effect mediated by IGF-1 requires phosphorylation of mutant huntingtin at S421, in the absence of phosphoryabrogate the toxicity of other proteins containing an expanded polyQ tract. One interesting candidate is the lation of huntingtin, IGF-1 is still able to induce some neuroprotection. This suggests that in the context of androgen receptor whose CAG expansion results in spinal and bulbar muscular atrophy (SBMA) or Kennedy's mutant huntingtin-induced cell death, IGF-1 mediates its neuroprotective effect not only via a direct action of disease (Fischbeck et al., 1999) . Indeed, the androgen receptor has recently been shown to be a substrate of Akt on huntingtin protein but also via the phosphorylation of other substrates that increase neuronal survival.
Akt (Lin et al., 2001 ). However, it is not known whether this phosphorylation plays a role in the toxicity induced Several substrates of Akt such as Bad, FOXOs, and caspase-9 that promote neuronal survival when phosby the mutant polyQ androgen receptor. By scanning proteins that contain an expanded polyQ stretch and phorylated by Akt have been described (Brunet et al., 2001 ). Those substrates, as well as others that remain that are responsible for this class of neurodegenerative disorders, we found, for example, that ataxin-1, the proto be identified, could also participate in mediating the neuroprotective effect elicited by IGF-1 and Akt on mutein responsible for spinal and cerebellar ataxia type 1, contains a putative phosphorylation site for Akt (data tant huntingtin-induced cell death.
Expansion of CAG trinucleotide repeats in otherwise not shown). If phosphorylation by Akt inhibits death induced by mutant ataxin-1, together with this study, we unrelated proteins is known to be the cause of at least as well as developing drugs that activate and/or prevent alteration of the Akt pathway could possibly lead to new therapeutic interventions in HD.
Experimental Procedures
Descriptions of constructs, cell culture, transfection, and protein extracts may be found as supplemental data at h t t p : / / w w w . developmentalcell.com/cgi/content/full/2/6/831/DC1.
Huntingtin Phospho-Antibody S421
A phosphopeptide of the following sequence was synthesized: CSGGRSRSGpSIVELI, and coupled to KLH (Neosystem, Illkirch, France). A polyclonal antibody to the KLH-coupled peptide was obtained and affinity purified as previously described (Neosystem; Datta et al., 1997). inhibition of mutant huntingtin-induced toxicity by Akt
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